Johnson & Johnson (LON: 0R34)

London flag London · Delayed Price · Currency is GBP · Price in USD
146.80
+0.20 (0.14%)
Dec 18, 2024, 8:00 AM BST
-0.82%
Market Cap 276.66B
Revenue (ttm) 65.44B
Net Income (ttm) 10.96B
Shares Out n/a
EPS (ttm) 4.51
PE Ratio 25.25
Forward PE n/a
Dividend 3.85 (2.62%)
Ex-Dividend Date Nov 26, 2024
Volume 28,478
Open 145.00
Previous Close 146.60
Day's Range 143.55 - 146.80
52-Week Range 143.14 - 165.71
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Jan 22, 2025

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company’s Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lu... [Read more]

Industry Pharmaceutical Preparations
Founded 1886
Employees 131,900
Stock Exchange London Stock Exchange
Ticker Symbol 0R34
Full Company Profile

Financial Performance

In 2023, Johnson & Johnson's revenue was $85.16 billion, an increase of 6.46% compared to the previous year's $79.99 billion. Earnings were $35.15 billion, an increase of 95.94%.

Financial numbers in USD Financial Statements

News

There is no news available yet.